Sign up to save your podcasts
Or
Share 30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 17 Critical Material Attributes (CMAs) in Cannabis and Psychedelic Manufacturi
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 17 Critical Material Attributes (CMAs) in Cannabis and Psychedelic Manufacturi
This podcast episode explores Critical Material Attributes (CMAs) in botanical drug manufacturing, focusing on cannabis and psychedelics. The discussion covers key aspects including:
- The unique challenges of working with botanical materials compared to synthetic drugs
- Important CMAs like moisture content, particle size, and microbial load that affect product quality
- How cultivar selection impacts chemical profiles and final product characteristics
The episode emphasizes how consistent CMAs are fundamental to ensuring product safety, quality, and regulatory compliance in botanical drug manufacturing
View all episodes
By Jim Mitchell and Google NotebookLMThis podcast episode explores Critical Material Attributes (CMAs) in botanical drug manufacturing, focusing on cannabis and psychedelics. The discussion covers key aspects including:
- The unique challenges of working with botanical materials compared to synthetic drugs
- Important CMAs like moisture content, particle size, and microbial load that affect product quality
- How cultivar selection impacts chemical profiles and final product characteristics
The episode emphasizes how consistent CMAs are fundamental to ensuring product safety, quality, and regulatory compliance in botanical drug manufacturing